Anti-TNF, a magic bullet in cancer immunotherapy?

Anti-TNF, a magic bullet in cancer immunotherapy?

Abstract Immune checkpoint blockers (ICB) have revolutionized cancer therapy. However, complete response is observed in a minority of patients and most patients develop immune-related adverse events (irAEs). These include colitis, which can be treated with anti-tumor necrosis factor (TNF) antibodies...

Full description

Bibliographic Details
Main Authors: Anne Montfort, Carine Dufau, Céline Colacios, Nathalie Andrieu-Abadie, Thierry Levade, Thomas Filleron, Jean-Pierre Delord, Maha Ayyoub, Nicolas Meyer, Bruno Ségui
Format: Article
Language:English
Published: BMJ Publishing Group 2019-11-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Tumor necrosis factor
Melanoma
Anti-PD-1
Anti-CTLA-4
Infliximab
Certolizumab
Online Access:http://link.springer.com/article/10.1186/s40425-019-0802-y

Internet

http://link.springer.com/article/10.1186/s40425-019-0802-y

Similar Items